Brief: Recursion Pharmaceuticals Inc - Appoints Vicki Goodman As Chief Medical Officer Effective April 6, 2026
25/03/2026 13:18
Recursion Pharmaceuticals Inc RXRX.O: RECURSION PHARMACEUTICALS INC - APPOINTS VICKI GOODMAN AS CHIEF MEDICAL OFFICER EFFECTIVE APRIL 6, 2026 Source text: ID:nGNX9CSMHm Further company coverage: RXRX.O
Recent news on Recursion Pharmaceuticals
See all newsBrief: Tempus And Recursion Extend Existing Data License Agreement And Enter New License Agreement For Recursion’S RNA Foundation Model
Brief: Recursion Pharmaceuticals Enters Amendment To Master Agreement With Tempus On Sept 15, 2026 - SEC Filing
Recursion Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
Recursion Pharmaceuticals Q2 revenue misses estimates, cuts 2026 expense outlook
Brief: Recursion Pharmaceuticals Q2 Operating Revenue USD 7.303 Million Vs. IBES Estimate USD 11.9 Million